Biotech VC Funds

Singularity University (SU) is a global learning and innovation community aimed at leveraging exponential technologies to address humanity's grand challenges. Through its Ventures program, SU supports startups that aim to make a significant global impact, focusing on industries such as biotechnology, healthcare, AI, and sustainability. SU Ventures has an impressive portfolio of companies that have collectively raised nearly $1 billion. Notable investments include Matternet, which pioneered drone delivery systems for medical supplies; Getaround, a leading car-sharing platform; and Be My Eyes, an app connecting visually impaired individuals with volunteers for real-time assistance. Other significant companies in their portfolio are Hala Systems, which provides technology-driven solutions for conflict zones, and Nexleaf Analytics, which develops sensor technologies for health and environmental monitoring. SU's investments emphasize innovative solutions that combine advanced technology with real-world applications to create sustainable and scalable impacts. Singularity University's Venture Fund I has also supported companies like Litesprite, which creates therapeutic gaming experiences, and ImpactVision, which uses hyperspectral imaging to improve food safety and quality. These investments highlight SU's commitment to fostering companies that not only push technological boundaries but also contribute to societal well-being.

Sinovation Ventures, founded in 2009 by Dr. Kai-Fu Lee, is a leading Chinese venture capital firm specializing in early to growth-stage investments. The firm focuses on sectors such as artificial intelligence, robotics, automation, semiconductors, and healthcare technology. With a presence in both China and the United States, Sinovation Ventures has raised over $3 billion across multiple funds. Notable investments by Sinovation Ventures include companies such as Niu Technologies, Planetary Resources, Securly, TuSimple, VIPKid, WeRide, Wonder Workshop, and Zhihu. These investments highlight the firm's commitment to backing innovative companies that leverage advanced technologies to address significant market opportunities and challenges. Sinovation Ventures has a strong track record of successful exits, including the public listing of Zhihu, China's leading question-and-answer platform, and the acquisitions of companies like Securly and TuSimple, an autonomous trucking technology company. The firm is currently targeting $500 million for its fifth fund, having already completed a first close of $200 million. This new fund continues to focus on AI and other advanced technologies, aiming to drive significant advancements and commercial success in these fields​.

Siparex is a prominent independent private equity firm based in France, managing over €3.7 billion in assets. The firm specializes in supporting companies across various stages of growth, from startups to intermediate-sized enterprises (ETIs). Siparex operates through multiple strategies, including ETI, Midcap, Mezzanine, Entrepreneurs, XAnge, TiLT Capital, and Territoires, enabling them to address diverse investment needs. Notable investments by Siparex include Efectis, a specialist in fire and explosion risk assessment, Green Fusion, which develops cloud-based energy management systems, and Capron Podologie, a leader in podiatry equipment. Siparex's approach is characterized by close collaboration with company management to implement effective solutions and drive both financial and extra-financial performance. The firm has a strong international presence with nine offices, including locations in France and abroad, and partnerships in Africa and North America, facilitating global reach and local expertise. Siparex is committed to being a responsible investor, integrating ethical considerations and sustainability into its investment decisions. In recent years, Siparex has continued to grow its assets under management through active fundraising, exemplified by the success of its Siparex ETI 5 fund, which closed at €450 million, and TiLT Capital's first fund, which raised €320 million.

SIS Ventures is an Edinburgh-based impact venture capital investor founded in 2018 as a wholly-owned subsidiary of SIS Group (Social Investment Scotland). Authorised and regulated by the FCA and Scotland's first signatory to the Operating Principles for Impact Management, SIS Ventures provides equity or debt financing to purpose-driven Scottish companies with global ambitions, targeting investments that generate conventional financial returns alongside measurable social or environmental outcomes aligned with the UN Sustainable Development Goals. The firm's leadership includes Chair David Ovens, Social Investment Scotland CEO Alastair Davis, Head of SIS Ventures Jill Arnold, and Executive Director Arran Dewar. SIS Ventures manages two main vehicles: the Impact First Fund (launched 2019, approximately GBP 5.6 million deployed over five years into 14 businesses that subsequently unlocked around GBP 65 million in follow-on funding) and Impact Fund II (targeting up to GBP 5 million in additional capital). Although broadly sector-agnostic, the firm concentrates on IP-rich companies in life sciences, climate tech, cleantech, circular economy, and agribiotech. Check sizes are typically GBP 100,000 to GBP 500,000 with lead-round capability. The firm leads rounds and has invested in 16 companies, including MiAlgae — the microalgae-based sustainable omega-3 producer where SIS led an $18.5 million Series A alongside Scottish Enterprise, having first backed the company with GBP 350,000 in 2022 — and a disclosed exit to Darktrace. Two new investments were made in the 12 months to early 2025. SIS Ventures operates at the frontier of Scotland's deep-tech and sustainability ecosystem, providing patient impact capital to founders who might otherwise struggle to access early-stage equity in a market where most VC activity concentrates in London and the South East.

SixThirty Ventures, founded in 2013 and based in St. Louis, Missouri, is a global venture capital firm investing in early-stage companies at the intersection of health, wealth, and privacy. The firm focuses on sectors such as fintech, insurtech, cybersecurity, and digital health. Notable investments include Reblaze, which provides cloud-based protection for web platforms; Silverfort, which secures authentication and authorization within corporate networks; and Bankjoy, a provider of modern banking technology solutions for credit unions. Other key investments are CogniCor, an AI-based cognitive virtual assistant platform, and Bloq, which delivers enterprise-grade blockchain technology. SixThirty Ventures typically invests in late seed-stage startups that have market traction and are starting to earn revenue. The firm supports these startups through a combination of funding, mentorship, and connections, helping them to scale and succeed. The global team, including experienced professionals like Atul Kamra and Ginna Baik, provides strategic counsel and support from day one, leveraging a vast network of corporate partners and advisors.

SJF Ventures is a leading venture capital firm that focuses on investing in high-growth companies driving positive environmental and social impact. Notable investments include companies like Vital Farms, a leader in pasture-raised eggs, and Nextracker, a solar energy solutions provider. SJF Ventures primarily targets industries such as clean energy, climate tech, sustainable food, education, and health. The firm’s geographic focus spans across the U.S. and select global markets, with offices in Durham, New York, San Francisco, and Seattle. SJF Ventures employs a robust investment strategy, focusing on expansion-stage companies with scalable impact solutions. They prioritize rigorous due diligence, continuous value addition, and impact measurement. The fund typically leads investment rounds, providing average checks ranging from $1 million to $10 million. Startups looking to engage with SJF Ventures are advised to demonstrate clear impact metrics and scalable business models. The firm’s team comprises experienced professionals like David Kirkpatrick, Co-Founder and Managing Director, based in Durham, and Arrun Kapoor, Managing Director in New York. Their collective expertise spans over decades in impact investing, ensuring a deep engagement with portfolio companies to accelerate growth and impact. With a track record of 84 investments, SJF Ventures is recognized for its significant contributions to sustainability and social good. The firm’s leadership in the impact investing ecosystem is further highlighted by its role in co-founding Impact Capital Managers, an association of impact-focused funds. For startups, SJF Ventures offers not just capital but a partnership aimed at achieving long-term positive change.

Skyline Ventures is a Palo Alto-based life-sciences venture capital firm founded in 1997 by John G. Freund and Eric M. Gordon, both of whom came to venture capital from medical and healthcare operating backgrounds. A defining feature of the firm is that every investment professional holds either an MD or PhD, enabling deep scientific diligence on the product-focused healthcare companies Skyline backs. Investment focus is concentrated in US-based small-molecule and protein therapeutics, medical devices, diagnostics, and the platform technologies that underpin drug discovery and life-science research. The firm has raised approximately $800 million across multiple vehicles; its latest fund, Skyline V, holds $350 million in committed capital and was sized to back 15 to 18 portfolio companies. Skyline leads rounds and applies unusually explicit check-sizing discipline: the firm typically invests $15 million to $25 million of total capital per portfolio company across multiple rounds, with first cheques in the $10 million to $15 million range. Across roughly 46 unique portfolio companies and 102 total deals on record, the firm has generated 10 IPOs and 26 acquisitions. Landmark names include Intuitive Surgical, Sutro Biopharma (which listed on NASDAQ in September 2018), and Theravance Biopharma. John Freund continues to serve as Founder and Managing Partner, supported by a compact team of around seven investment professionals. Skyline's approach is to engage deeply with each company across multiple rounds rather than spreading capital broadly -- a philosophy that prioritizes scientific conviction over portfolio diversification. The firm currently manages Skyline V through its harvest cycle, with limited new deployment in recent years as it focuses on maximizing outcomes across existing holdings.

Skypoint Ventures is a Flint, Michigan-based venture capital, real-estate, and operating-company platform founded in 2013 by Phil Hagerman, a serial pharmacy entrepreneur who previously founded and served as CEO and chairman of Diplomat Pharmacy -- the largest US specialty-pharmacy company before its acquisition. Skypoint sits at the intersection of early-stage seed investing, downtown Flint real-estate revitalization, and operating-company incubation. Hagerman has invested an estimated $50 million into reviving Flint's downtown, including the renovations of the Dryden Building and the Ferris Furs Building, renamed the Ferris Wheel -- a coworking and innovation hub that hosts the 100K Ideas non-profit incubator. On the venture side, Skypoint operates a seed-stage fund with a wide aperture covering healthtech, SaaS, consumer products, media, hardware, pharmaceuticals, medical devices, biotechnology, and cleantech. The firm has 20 disclosed investments including Article One eyewear (2017), ProBook, AllIn productivity software, NeverEnding, and most recently Pivotal Health (December 2024). Skypoint also holds majority-owned operating subsidiaries: Forum Health, a national functional-medicine clinic network, and Divide By Design, a demountable wall-systems manufacturer. The leadership team includes Founder and CEO Phil Hagerman, Managing Director Bryce Moe, President and Chief Innovation Officer David Ollila, and Vice President Dan Farrell. The firm's approach blends capital investment with direct operational ownership and community development, treating the revitalization of Flint as inseparable from its technology investment thesis -- a distinctive positioning that sets Skypoint apart from conventional VC platforms.

Skyview Capital, founded in 2005 and based in Los Angeles, is a private equity firm focused on corporate carveouts, special situation buyouts, and distressed asset acquisitions. The firm specializes in sectors such as software, technology, manufacturing, consumer products, and business services. Skyview Capital is known for its ability to transform and scale businesses by providing the necessary financial resources and operational expertise to unlock their full potential. The firm’s strategy emphasizes long-term value creation through organic growth, growth via acquisition, and strong partnerships with executive teams. Skyview places great importance on integrity, transparency, and collaboration, fostering close relationships with both portfolio companies and investors. The firm operates a robust Operations team, spanning the US, Europe, and Asia, which plays an active role in integrating and improving acquired companies. Skyview Capital has made over 49 investments, with notable exits including companies like Fidelis Security and Digital Lumens. The firm’s portfolio includes diverse companies across various industries, including food products like MeliBio and entertainment software like Vurbl. Skyview continues to focus on high-impact acquisitions, aiming to create sustainable growth across its portfolio while adhering to strong environmental, social, and governance (ESG) principles.

Slater Technology Fund, based in Providence, Rhode Island, is an evergreen, not-for-profit seed fund dedicated to supporting early-stage technology startups within the state. Established in 1997, Slater focuses on ventures in the life sciences, software, and energy sectors, emphasizing innovative technologies and scalable business models. The fund aims to foster economic growth by providing financial resources and mentorship to high-potential startups. Slater Technology Fund recently secured $12 million in federal funding from Rhode Island's State Small Business Credit Initiative (SSBCI) to bolster its mission of seeding high-growth companies in Rhode Island. This funding will be used to support dynamic startups, particularly those led by diverse founders and those emerging from university research​. The fund is led by a team of experienced professionals, including Managing Director Thorne Sparkman, who actively engages with the local entrepreneurial ecosystem through teaching and advisory roles at Brown University and other institutions. The fund’s portfolio includes a variety of successful exits and active companies that have made significant impacts in their respective industries​. For entrepreneurs looking to engage with Slater Technology Fund, demonstrating a strong alignment with their focus on innovative technology and potential for significant impact within Rhode Island is crucial. The fund's commitment to fostering local talent and supporting early-stage ventures makes it a pivotal player in the state's venture development efforts.

Slow Ventures is a prominent early-stage venture capital firm that invests in companies positioned at the heart of the technology industry, as well as those exploring the edges of science, society, and culture. With offices in San Francisco, New York, and Boston, Slow Ventures has built a reputation for backing transformative ideas and helping visionary founders turn those ideas into impactful businesses. Their portfolio includes high-profile startups such as Allbirds, Robinhood, and Pinterest, which demonstrate the firm’s commitment to disruptive innovation across multiple sectors. Slow Ventures’ investment philosophy revolves around empowering companies that have the potential to shift entire industries. Whether it's a consumer product revolutionizing the way people think about sustainability, or a fintech platform democratizing access to financial markets, Slow Ventures seeks founders who are deeply curious, passionate, and mission-driven. The firm typically writes checks at the pre-seed, seed, and Series A stages, offering flexible financial support and hands-on mentorship to help startups grow from concept to full-scale operations​. With a focus on creating long-term value, Slow Ventures is deeply involved in the entrepreneurial journey, providing founders with access to a community of experienced advisors and resources. Their approach goes beyond financial investment, aiming to nurture companies that can positively impact society. They also have a strong interest in the convergence of technology with cultural and scientific developments, giving them a unique edge in spotting emerging trends and opportunities​.

SmartGate VC is a pre-seed venture capital firm based in California and Armenia, with a strong focus on deep tech investments at the intersection of AI, healthcare, biotech, security, and IoT. Since its founding, the firm has built a robust portfolio of 31 companies, actively participating in their journey from pre-seed to seed stages. Notable investments include Krisp, a noise cancellation technology company, and SuperAnnotate, known for its fast annotation platform for AI training. Recently, they invested in Tactun, a company pioneering no-code controllers for smart manufacturing, which aims to connect intelligence to the physical world and revolutionize manufacturing processes. SmartGate VC emphasizes a strong collaborative approach, leveraging its network of industry professionals, scientists, and entrepreneurs through their Hero House tech hubs in California and Yerevan. These hubs serve as incubators for innovative ideas and provide essential support to startups in their growth phases. Their strategy involves identifying promising tech leaders early on and providing them with the necessary capital, talent, and industry connections to succeed. The firm has shown significant success in raising additional funds for its portfolio companies, with every $100K invested resulting in $6.5M raised on average. The firm is led by experienced partners such as Ashot Arzumanyan and aims to support the next generation of tech entrepreneurs in bringing transformative solutions to market.

SMBC Venture Capital, established in 2005, is the corporate venture capital arm of Sumitomo Mitsui Banking Corporation (SMBC), headquartered in Tokyo, Japan. The firm focuses on early to growth-stage investments across a diverse range of industries, including technology, healthcare, financial services, and mobility solutions. With a portfolio of over 656 investments and significant co-investment partnerships, SMBC Venture Capital plays a vital role in fostering innovation within Japan's startup ecosystem. Notable recent investments include companies like SmartNews, which became a unicorn in 2019, and Luup, a micromobility service that provides essential transport solutions across Japan. SMBC Venture Capital's strategic approach combines rigorous risk assessment with a willingness to support promising startups even in their nascent stages. This flexibility and foresight have enabled the firm to back companies that address critical market needs and have the potential for significant growth​. The firm is led by a team of seasoned professionals, including President Tomofumi Saeki and Deputy General Manager Naoki Fujita, who bring extensive experience in investment strategy and corporate finance. SMBC Venture Capital's strong alignment with its parent company's resources and network allows it to provide substantial operational support and strategic guidance to its portfolio companies, facilitating their growth and success in both domestic and international markets.

SNR is a San Francisco-based venture capital firm that focuses on early-stage investments, particularly in companies operating within the information technology sector. Established to back innovative founders working in deep tech, SNR invests in transformative technologies like artificial intelligence (AI) and machine learning (ML). The firm has a clear emphasis on solving real-world problems with scalable solutions. SNR’s portfolio includes notable investments like Mesh, a Series A recipient, which raised $22 million with support from investors including Samsung NEXT and Galaxy Digital. The firm typically seeks out opportunities that can leverage AI and frontier technologies for significant industry disruptions. The firm’s mission revolves around amplifying the “signal” — the meaningful innovation — in a world crowded with background noise. By focusing on high-impact startups, SNR aims to drive the next wave of technological breakthroughs​.

Social Capital, founded in 2011 by Chamath Palihapitiya and Ted Maidenberg, is a venture capital firm based in Menlo Park, California. The firm focuses on investing in a wide range of sectors, including healthcare, financial services, education, and enterprise software, emphasizing companies that aim to solve significant societal problems through technology and innovation​. Over the years, Social Capital has made notable investments in companies such as Slack, Yammer, and Opendoor Technologies. The firm gained attention for its SPAC (Special Purpose Acquisition Company) strategy, which led to the successful public listing of companies like Opendoor​. Social Capital manages a substantial portfolio with 488 investments and 176 exits. The firm has a unique approach that combines traditional venture capital with a strong focus on social impact and systemic change. Chamath Palihapitiya, the CEO, continues to lead the firm, driving its mission to tackle complex global challenges through innovative solutions​.

Social Impact Capital, founded in 2016 by Sarah Cone and based in New York City, is an early-stage venture capital firm dedicated to addressing critical environmental and social challenges. The firm’s investment strategy, called "impact arbitrage," focuses on seed-stage companies, helping them scale and secure follow-on funding from top-tier VCs. This approach has led to a 100% follow-on financing rate for its portfolio companies. Notable investments include Prometheus Fuels, Andela, and OpenInvest, with the latter being acquired by JP Morgan. The portfolio spans various sectors such as clean tech, health, and social justice, featuring companies like Totus Medicines, Charm Industrial, Aether Diamonds, and Menten AI. Led by Sarah Cone, an experienced venture capitalist with a background in tech and nonprofits, Social Impact Capital also includes key members like Peter Bruce-Clark and Melody Donoso. The firm supports founders with innovative, scalable solutions, making it a significant player in impact investing, combining financial returns with positive societal impact.

Social Starts is a venture capital firm that uses a data-driven approach to identify and invest in early-stage companies. Founded in 2012, the firm has a focus on sectors such as health tech, digital brands, e-commerce, employment platforms, next-generation food, and education. Social Starts operates a series of funds, including the "Social Starts Health and Happiness" fund, which targets startups aiming to improve human health and well-being​. The firm's investment range typically falls between $50,000 and $1 million, with a sweet spot around $500,000. Social Starts is known for supporting companies from their inception through to Series A rounds, leveraging a robust network of advisors and industry experts to help portfolio companies grow​. With a presence in major innovation hubs like San Francisco, New York, Los Angeles, Tokyo, London, Austin, Boston, and Singapore, Social Starts has built a diverse portfolio. The firm is particularly noted for its ability to find and back high-potential startups in emerging segments by employing advanced analytics to guide its investment decisions​.

Sofimac Partners is a seasoned French venture capital and private equity firm with a focus on supporting high-growth SMEs and innovative startups. Established over 40 years ago, the firm specializes in early-stage investments, particularly in sectors like life sciences, healthtech, deeptech, and industrial engineering. Based in cities like Paris, Lyon, Rennes, and Marseille, Sofimac has an extensive national presence, allowing it to stay close to key innovation hubs across France. Sofimac manages over €750 million in assets, with a portfolio of more than 90 active companies. Their investment strategy focuses on early-stage startups, often providing seed to Series A funding with ticket sizes ranging from €100,000 to €2 million. They are also committed to long-term partnerships, with the ability to follow on in subsequent rounds, supporting startups through their growth journey. Notable companies in their portfolio include Diabeloop, an innovator in diabetes management, and Mob-Energy, which develops robotic electric vehicle charging solutions. The firm also runs the Pertinence Invest 2 fund, which specifically targets disruptive technologies emerging from academic research, particularly in healthcare and engineering. With a hands-on approach, Sofimac works closely with founders, offering not just capital but strategic guidance and access to a broad network of industry experts and institutional partners.

Sofinnova Partners is a leading European venture capital firm, established in 1972, that focuses on life sciences, healthcare, and sustainability. With offices in Paris, London, and Milan, the firm manages over €2.8 billion in assets and has backed more than 500 companies globally. Sofinnova Partners specializes in supporting companies across the full spectrum of life sciences, from seed-stage to later growth, with dedicated funds for biopharmaceuticals, medical devices, digital medicine, and industrial biotechnology. The firm is known for its hands-on approach, partnering with entrepreneurs to develop transformative technologies that address significant healthcare challenges. Notable investments include groundbreaking companies in gene therapy, precision medicine, and sustainability-focused biotech. Sofinnova’s portfolio includes innovations across sectors such as biopharma, medtech, and AI-powered digital health solutions. Sofinnova has a strong track record of creating market leaders, driven by its deep scientific expertise and commitment to long-term partnerships. Through strategies like Sofinnova Capital and Sofinnova Crossover, the firm supports companies from inception through IPOs or acquisition, playing a critical role in advancing innovations that improve lives globally.

SoGal Ventures is a pioneering venture capital firm co-founded by Pocket Sun and Elizabeth Galbut in 2015. It stands out as the first women-led, next-gen venture capital firm, focusing on investing in diverse founding teams in the US and Asia. SoGal Ventures capitalizes on the three significant arbitrage investment opportunities of our time: undervalued founders, undercapitalized geographies, and underserved problems. The firm has a robust portfolio featuring companies that are revolutionizing how people live, work, and stay healthy. Notable investments include Function of Beauty, Everly Health, Lovevery, and Ceremonia. These companies reflect SoGal's commitment to backing startups that drive positive societal impact and innovation. Pocket Sun and Elizabeth Galbut have been recognized for their contributions to the venture capital industry. Pocket has been featured on the cover of Forbes and recognized as one of the youngest persons on the Forbes 30 Under 30 list in VC. Elizabeth has been named one of Entrepreneur Magazine’s 100 Most Powerful Women and a Forbes 30 Under 30 honoree. Both founders have built a strong global brand and network, advocating for women's potential as founders and funders.

Soma Capital, founded in 2015 by Aneel Ranadive, is a venture capital firm based in San Francisco, California. The firm focuses on early-stage investments in software and technology startups that aim to automate and improve various sectors. Soma Capital's approach is stage- and sector-agnostic, investing globally in regions such as Africa, the Middle East, South America, and Asia. Soma Capital has raised several funds, with its latest, Soma Capital Fund III, closing at $412 million in January 2022. This fund is used to support unicorn and startup software companies around the world. The firm has made significant investments in over 1,097 companies, including notable names like Cruise, Rappi, Ironclad, Human Interest, Razorpay, Rippling, and Lambda School. Soma Capital has seen 19 of its portfolio companies achieve unicorn status and has been involved in more than 140 exits. The firm’s leadership includes Founder and Managing Partner Aneel Ranadive, along with partners like Mir Faiyaz and Nikhita Jaaswal. Soma Capital's mission is to invest in transformative technology solutions that can impact billions of people globally​.

Sony Innovation Fund is the corporate venture capital arm of Sony Group, established in 2016. SIF invests in early-stage startups with a focus on transformational technologies that shape the future of business, entertainment, and society. The fund operates globally, with offices in the U.S., Japan, EU, Israel, and India, managing over $250 million in assets. SIF targets a wide range of sectors including entertainment, fintech, healthcare, IoT, mobility, deep tech, and sensor technologies. They support startups by providing not only capital but also access to Sony’s extensive technical expertise, global network, and R&D capabilities. This strategic support helps startups scale and innovate within their industries. The fund's portfolio includes companies like Arkose Labs, which focuses on AI/ML for trust and safety, and Truepic, which works on digital content authentication. SIF also places significant emphasis on Environmental, Social, and Governance (ESG) issues, integrating these considerations into their investment process to create long-term value. The leadership team features experienced professionals like Gen Tsuchikawa, Chairman of Sony Ventures Corporation, and Austin Noronha, Managing Director in the U.S., who drive the fund’s strategic vision and operations. SIF continues to explore and invest in innovative technologies that align with Sony’s mission of bringing creativity and promising innovations to a connected world.

Sopris Capital, founded in 2002 and based in Aspen, Colorado, is a venture capital firm specializing in growth equity investments. The firm focuses on technology-enabled business services and SaaS companies, particularly those addressing critical pain points in sectors such as healthcare, education, and enterprise software. Sopris Capital leverages its long-term capital structure to provide patient and flexible funding. This approach allows them to support companies through various stages of growth. Their portfolio includes investments in companies like Clinetic, which focuses on accelerating clinical research through EHR data, and Medcase, a healthcare technology system provider. The firm’s leadership team includes founder and CEO Andrew Paul, along with partners like Mark Groner and Abinav Sankar, who bring extensive experience in private equity and venture capital. Sopris Capital aims to be a value-added partner, offering strategic guidance and leveraging their networks to help portfolio companies achieve their growth objectives.

SOSV is a leading venture capital firm dedicated to deep tech investments, particularly in human and planetary health. Founded by Sean O'Sullivan, SOSV manages over $1.5 billion in assets and supports more than 1,000 companies across 60 countries. Some of its most notable investments include Upside Foods, Perfect Day, and Novoloop, which focus on sustainable food and materials innovations. The firm’s main programs are HAX and IndieBio. HAX, located in Shenzhen, San Francisco, and Newark, supports startups in industrial automation, health tech, and manufacturing with pre-seed funding and advanced lab resources. IndieBio, with branches in San Francisco and New York, focuses on life sciences, backing startups in agriculture, food tech, and biopharma. These programs offer investments ranging from $250,000 to $525,000 and provide ongoing support through additional funding rounds. SOSV’s strategy emphasizes hands-on assistance, providing founders with access to extensive lab facilities and a global network of over 1,000 co-investors. This approach has led to a high success rate, with 62% of program graduates raising follow-on funding within a year. The firm also values diversity, with a significant portion of its founders being female and from outside the US. The leadership team includes experienced partners like Cyril Ebersweiler and Duncan Turner, who oversee HAX, and Po Bronson and Pae Wu, who lead IndieBio. SOSV also organizes high-profile events, such as the SOSV Climate Tech Summit, to showcase and support its portfolio companies.

Sound Ventures, co-founded by Ashton Kutcher and Guy Oseary, is a Los Angeles-based venture capital firm specializing in early-stage investments in transformative technologies. The firm recently closed its $240 million AI fund, aiming to back pioneering companies in the artificial intelligence space, such as OpenAI, Anthropic, and StabilityAI. Sound Ventures' investment strategy focuses on identifying and supporting exceptional founders developing technologies with significant societal impact. Their portfolio includes high-profile companies like Airbnb, Uber, Flexport, and GitLab, reflecting their broad investment scope across industries. The firm leverages its deep expertise in both technology and entertainment to provide strategic support and industry connections to its portfolio companies. Led by General Partners Effie Epstein, Ashton Kutcher, and Guy Oseary, Sound Ventures manages over $1 billion in assets. They are known for their proactive approach in guiding startups from ideation through to scaling, emphasizing a strong partnership with founders throughout the process. For startups looking to engage with Sound Ventures, it's beneficial to demonstrate innovative AI applications or technologies that promise significant advancements and societal benefits. Reaching out with well-prepared presentations and leveraging networks can facilitate initial contact.

The South Australian Venture Capital Fund (SAVCF) is a A$50 million government-backed co-investment vehicle established in 2017 by the South Australian Government Financing Authority (SAFA) to back innovative early-stage companies headquartered in South Australia. The fund is managed by Artesian Venture Partners, Australia's largest and most active early-stage VC, which runs SAVCF out of its Adelaide office as part of a broader Asia-Pacific platform with additional offices in Sydney, Melbourne, Singapore, and Shanghai. SAVCF only backs companies that have demonstrated a market, commenced revenue or customer validation, and can scale capital-efficiently into national and global markets. Deployment strategy targets 10 to 20 pre-Series A investments at A$1 million to A$2 million per deal, plus 5 to 12 Series A investments at roughly A$2.5 million, always matched with at least 50% co-investment from other VCs, angels, or strategics. Typical check sizes run $1 million to $2.5 million. The portfolio spans biotech, deep tech, space and IoT, and SaaS, and includes BiomeBank (gut microbiome clinical-stage biotech), Ferronova (cancer diagnostics), Fivecast (OSINT and security analytics), Fleet Space Technologies (low-power satellite IoT), Myriota (satellite IoT), Lumary (healthcare SaaS processing over A$2.5 billion of NDIS services), Kid Sense (paediatric therapy services), Kindship (disability-parent social network), Pearler.AI (tender and grant response AI), Seonix Bio (genetic glaucoma risk), and Val.AI (home energy efficiency). The SAVCF structure reflects a deliberate policy objective: to develop South Australia's innovation ecosystem by ensuring promising local companies attract the co-investment and mentorship needed to scale beyond the state's borders, with Artesian providing the institutional investment infrastructure.

Sovereign's Capital, founded in 2012 and headquartered in Atlanta, Georgia, is a private equity and venture capital firm that focuses on investments in companies led by faith-driven teams. The firm invests in a variety of sectors including healthcare, information technology, and consumer products. They operate with a mission to generate outsized returns while making a positive impact. Their investment strategy is divided into five main areas: direct investments in profitable lower middle market companies, early-stage technology companies, publicly-traded companies, domestic real estate, and fund of funds investments. They also offer business consulting services to mature companies preparing for ownership and leadership transitions. Notable investments by Sovereign's Capital include Brindlee Mountain Fire Apparatus, a leading refurbisher and reseller of fire apparatus, and AM Technical Solutions, a specialty contractor providing clean room services for the semiconductor and life sciences industries. Sovereign's Capital has demonstrated flexibility in their investment approach, often structuring extended hold periods to promote long-term value creation and focusing on operational improvements, smart organic growth, and acquisition opportunities.

SP Ventures is a Brazilian venture capital firm specializing in early-stage investments in agritech and food technology across Latin America. Founded in 2007 and based in São Paulo, SP Ventures is a leader in supporting innovative solutions for agriculture, focusing on precision farming, agri-fintech, supply chain logistics, and sustainability. Its portfolio includes notable investments like Agrosmart, an IoT platform for precision farming, InCeres, a soil management system, and Pink Farms, the first vertical urban farm in Latin America. These startups develop technologies that enhance agricultural productivity while addressing global challenges like food security and sustainability. SP Ventures manages the AgVentures II fund, which has attracted significant backing from global leaders such as BASF and Syngenta. The fund focuses on pioneering technologies in agriculture, including biological inputs, digital financial services for farmers, and food safety innovations. The firm also aims to expand its reach across Latin America, with investments in countries like Argentina, Chile, and Mexico. Led by co-founder Francisco Jardim, SP Ventures takes a hands-on approach to nurturing startups, offering strategic support to scale businesses and drive sustainable growth. The firm believes agritech can play a transformative role in Latin America's economic and environmental future, actively seeking out entrepreneurs whose solutions align with this vision.

Space Capital is a New York-based venture capital firm specializing in early-stage investments within the space economy. Founded by Chad Anderson in 2012, the firm focuses on space technology stacks such as GPS, geospatial intelligence (GEOINT), and satellite communications (SatCom). These technologies serve as the backbone for industries across the globe, enabling innovations in sectors such as logistics, agriculture, and defense. The firm manages over $100 million in assets and operates with a deep understanding of the space sector. Their investment strategy emphasizes long-term potential, with a preference for startups that leverage space-based data and hardware to create transformative applications. Notable investments include companies like Made In Space and NanoRacks, which focus on space infrastructure and services. Space Capital is also known for its disciplined, thesis-driven approach to investing. The firm is actively involved in shaping the space ecosystem through its platforms like Space Angels, which connects investors with promising space startups, and Space Talent, a career platform designed to support the growing demand for skilled professionals in space and tech. By positioning itself as a leader in the space economy, Space Capital aims to capture the immense opportunities that will define the future of global industries​.

Spacecadet Ventures is a cutting-edge venture capital firm based in San Francisco, focusing on early-stage investments in groundbreaking industries such as artificial intelligence, biotechnology, and financial services. They have a diverse portfolio featuring companies like Eyebot, Cascade Biocatalysts, and Prophetic AI, showcasing their commitment to transformative technologies. Geographically, their investments are spread across North America and Europe. Spacecadet Ventures typically engages in seed to Series A rounds, with average check sizes around $3 million, often co-investing with prominent partners like Andreessen Horowitz and Village Global. Their strategy is anchored in leveraging marketing expertise to propel startups to success, aligning with their brand as "The Marketing VC." They are known for their hands-on approach, providing not just capital but also strategic guidance and industry connections. Key team members include Alexa Binns, a seasoned marketer with extensive experience in consumer tech and venture investments, supported by a team of industry veterans. Spacecadet Ventures prefers pitches that demonstrate innovative solutions with clear market potential and scalability. They are approachable and encourage startups to reach out through their website, emphasizing their openness to novel ideas and disruptive technologies. With a proactive investment style, they aim to be a catalyst for the next generation of industry leaders​.

Spark Capital is a prominent venture capital firm with a focus on investing in groundbreaking companies across sectors like consumer internet, media, software, and fintech. Founded in 2005, the firm has backed high-profile startups such as Twitter, Discord, and Cruise, leading early-stage rounds that propelled these companies to massive success. Spark’s portfolio also includes Postmates, which was acquired by Uber, and Harmonix, known for the popular "Rock Band" game franchise. The firm typically invests across all stages, from seed to growth, with a particular focus on companies that aim to disrupt existing markets. Spark's team members, such as co-founder Bijan Sabet, emphasize investing in founders who take big chances and challenge the status quo. The firm is highly selective, backing visionary entrepreneurs with innovative products that have the potential to reshape industries​. Geographically, Spark’s investments span the globe, with a presence in key markets like the U.S. and Europe. Their flexible and founder-first approach has positioned them as trusted partners for startups like Wayfair and Instawork.

Speedinvest, headquartered in Vienna, is a leading early-stage venture capital firm with more than €1 billion in assets under management. The firm focuses on pre-seed, seed, and early-stage investments across Europe. Speedinvest's portfolio includes notable companies like Bitpanda, Wefox, GoStudent, and TWAICE, reflecting their diverse investment focus spanning sectors such as fintech, deep tech, health tech, climate tech, and SaaS. Speedinvest operates six sector-focused teams: Deep Tech, Fintech, Health & TechBio, Climate Tech & Industrial Tech, Marketplaces & Consumer, and SaaS & Infrastructure. This specialized approach allows them to provide targeted support and resources to startups, helping them scale effectively​​. Since its inception in 2011, Speedinvest has made 497 investments and has seen 15 exits. Their investment strategy emphasizes hands-on support and leveraging their extensive network of industry experts, founders, and operational partners to foster the growth of their portfolio companies. Some recent investments include startups like Sylvera, Liefergrün, and Seqera Labs, all of which are making significant strides in their respective fields.

Spero Ventures, founded in 2018 and based in Burlingame, California, is a venture capital firm that invests in mission-driven technology companies. Their primary focus areas include wellbeing, sustainability, and sectors related to learning, work, and play. The firm is known for leading or co-leading investment rounds ranging from $3 million to $10 million, typically providing initial checks between $2 million and $4 million with reserves for follow-on investments. Notable investments by Spero Ventures include companies such as Tiny Health, Huckleberry, Tortuga AgTech, and Skillshare. They have made 64 investments to date and achieved several successful exits, including companies like Nana, Jopwell, and INDUS.AI. The leadership team consists of experienced investors like Shripriya Mahesh, Andrew Parker, and Sara Eshelman, all of whom have backgrounds in landmark companies such as eBay and Tesla. Spero Ventures emphasizes backing determined founders who are building technology solutions to create a hopeful future. Their investment strategy is conviction-based, focusing on long-term growth and impact.

Spiral Ventures is a venture capital firm headquartered in Singapore, with a focus on investing in early-stage startups across Southeast Asia and India. The firm, which was founded in 2017 after rebranding from IMJ Investment Partners, targets sectors such as fintech, logistics, artificial intelligence, healthcare, and the sharing economy. Their investments prioritize companies that address social needs and drive innovation in rapidly growing markets like Southeast Asia and India. Notable investments include PolicyStreet, a fintech company advancing inclusive insurance in Southeast Asia, SwipeRx, which connects pharmacies across Southeast Asia, and Dagangan, a digital FMCG distribution platform in Indonesia. Spiral Ventures offers more than just capital; they foster collaboration between startups and larger corporations, providing market access and strategic guidance to help scale their portfolio companies​. With a diverse team spanning Singapore, Indonesia, Japan, and India, Spiral Ventures is well-positioned to tap into local markets and support companies in navigating these dynamic ecosystems. Their mission is to invest in startups that can deliver both financial returns and significant social impact, aligning with the exponential growth expected in the region​.

Spring Lane Capital is a Boston-based private equity firm that specializes in providing "Hybrid Project Capital" for sustainable infrastructure sectors, including energy, food, water, transportation, and waste. Since its founding in 2017, the firm has focused on accelerating the deployment of small-scale, localized solutions that can drive significant environmental and economic impact. Spring Lane Capital's unique investment approach combines project equity for smaller-scale systems with additional growth capital, enabling companies to scale rapidly and access larger, more cost-effective capital as they mature. This model is particularly effective in sectors where traditional project finance is less accessible due to the smaller size or distributed nature of the assets. The firm has a strong portfolio that includes companies like Atlas Organics, which converts organic waste into compost, and EVCS, a fast-growing electric vehicle charging network on the West Coast. These investments reflect Spring Lane's commitment to supporting technologies that address pressing environmental challenges while offering strong financial returns. Spring Lane's strategy is to partner closely with management teams, providing not only capital but also strategic guidance and operational support to ensure long-term success. Their investment process is thorough, involving detailed market and technology assessments, to align both the firm's and the partner companies' goals.

Springhood Ventures is a Boston-based early-stage venture capital firm founded in 2018 by John Parker with a singular mission: to back emerging life science and healthcare companies transforming the health and care of people in their first two decades of life. The firm positions itself as the first venture capital firm broadly dedicated to children's health, investing on a mission-first basis in seed-stage pediatric medical solutions spanning drug discovery, neonatal diagnostics, predictive analytics, and medical devices. The investment thesis targets the intersection of high clinical need, exceptional innovation, and the development incentives unique to the child-health market, including rare pediatric disease vouchers and orphan designations. Founder and Managing Partner John Parker spent 25 years across venture capital, private equity, and hedge funds before launching Springhood. He previously created and managed CH Innovations, the impact-first venture capital subsidiary of the Charles H. Hood Foundation -- a Boston private foundation supporting pediatric research -- where Parker remains a trustee and runs its Program-Related Investment initiative. The portfolio is intentionally concentrated, with four disclosed investments including TMA Precision Health (pediatric precision-medicine risk analytics), FLAG Therapeutics (drug discovery), NeoPrediX (predictive analytics for neonatal, maternal, and perinatal health, the most recent new investment in September 2024), and a prior holding in Novonate, which was acquired by Laborie Medical in February 2023. Springhood's focus on the first two decades of life is both a moral and commercial thesis: pediatric drug development carries regulatory incentives that improve risk-adjusted returns, and the market is underserved by generalist life-science VCs whose portfolio prioritization naturally gravitates toward the larger adult patient populations.

SpringTide Ventures is an influential early-stage venture capital firm based in Cambridge, Massachusetts, specializing in HealthTech investments. With a strategic focus on digital health, medical devices, life sciences, and tech-enabled care delivery, the firm recently closed its second fund at $65 million, bringing its total assets under management to over $100 million. SpringTide Ventures has a history of backing groundbreaking companies like GreatExpectations.io, a leader in data quality tooling; Pathology Watch, an AI-powered dermatopathology platform; Debut Biotech, a pioneer in cell-free biomanufacturing; and OpenLoop, an end-to-end telemedicine enablement company. These investments highlight SpringTide's commitment to leveraging advanced technologies to enhance patient care and improve health outcomes. Founded by Austin Walters, the firm emphasizes a hands-on approach, working closely with its portfolio companies to navigate growth stages and achieve significant market impact. SpringTide Ventures invests primarily in seed and Series A rounds, focusing on startups that address critical healthcare needs with innovative solutions.

Sprint VC stands out by offering a unique approach to angel investing with its Angel SIP model, blending the advantages of being both an active angel investor and a passive limited partner. Sprint focuses on early-stage companies, especially in the seed and pre-series A stages, and invests across diverse industries like tech, fintech, and consumer goods. The fund operates primarily in India but is open to global investors, with a growing network of over 595 investors across seven countries. Sprint is known for its selective investment process, curating fewer than 2.5% of startups for its portfolio. They prioritize startups with strong product-market fit, large market potential, and early revenue generation. Their investment strategy includes co-investing at least 10% in every deal, ensuring alignment between fund managers and investors. Sprint’s average investment horizon ranges from 4-5 years in early-stage startups, aiming for 10X returns in higher-risk deals. With a 12% hurdle rate, it only charges profit share after surpassing this benchmark, demonstrating a high-performance-driven model. The leadership, including Salil Chakrabarty, brings deep domain expertise, favoring founders who show strong execution and scalability potential. For startups, Sprint values transparent financials and clear market traction, preferring to co-invest alongside well-regarded lead investors. Entrepreneurs can approach them through their platform, which allows interaction with Sprint’s experienced team, known for its rigorous due diligence and strong mentorship network.

SquareOne Venture Capital is a Berlin-based VC firm that focuses on pre-seed and seed investments in B2B technology startups. Formerly known as Paua Ventures, it was founded in 2010 and has built a strong reputation for being one of the first institutional investors on the cap table of early-stage startups. The firm supports founders solving complex problems in large markets, primarily in sectors like AI, SaaS, fintech, and deep tech. SquareOne provides a unique "first-customers-guarantee" to its portfolio companies, acting as an entrepreneurial partner and hands-on supporter from day one. Their approach emphasizes close collaboration with founders, offering not only financial backing but also access to a vast network of tech entrepreneurs, executives, and investors. This positions their portfolio companies for success in achieving follow-on funding from top-tier international funds. With a typical investment range of €1.5M to €3M, SquareOne has invested in notable companies such as Stripe, Pipedrive, and Wandelbots. The firm's portfolio reflects its commitment to building large, profitable category leaders across Europe. Their mission is clear: to be the most helpful partners on the cap table, providing enduring support through both successes and challenges, ensuring their founders' long-term success.

SR One, a leading trans-Atlantic biotechnology venture capital firm, focuses on translating innovative science into transformative medicines. Originally established in 1985 as the venture capital arm of GlaxoSmithKline (GSK), SR One completed its spin-out from GSK in 2020, marking a significant milestone in its journey. The firm successfully raised a $500 million fund, making it the largest first-time VC fund focused on U.S. and European biotech startups in 2020. This was followed by a second fund of $600 million, bringing their total assets under management to over $1.5 billion. SR One's investment strategy centers on building and supporting elite biotechnology companies through a "back-and-build" approach, providing both financial and operational support to advance programs through critical development stages. The firm operates out of key biotech hubs in Redwood City, California, Philadelphia, Pennsylvania, and London, UK, which allows it to leverage opportunities and provide regional expertise. Key team members include CEO Simeon George, who has been with the firm since 2007 and has played a pivotal role in several major investments such as CRISPR Therapeutics and Principia Biopharma. SR One's leadership and venture partners bring extensive experience in biotech investments and company creation.

SRMG Ventures is a media-focused venture capital fund that backs innovative companies across content creation, ad-tech, immersive entertainment, and digital media tools. Based in Saudi Arabia, they primarily invest in the MENA region but are open to global opportunities. Their portfolio features notable companies like Telfaz11, a leading Saudi media studio, 360Vuz, an immersive video platform, and Anghami, the top music streaming service in the Arab world. SRMG Ventures primarily targets early-stage investments, ranging from seed to Series B, with a flexible approach towards later rounds when aligned with their vision. Their investment strategy revolves around companies showing clear product-market fit and solid early traction. They provide significant follow-on capital, ensuring their portfolio companies have long-term growth potential. The fund offers a collaborative and founder-friendly approach, sometimes leading investment rounds, while other times co-investing with like-minded partners. They emphasize providing both financial support and deep industry expertise, leveraging their 50-year legacy in the media industry. Startups can expect strategic mentorship, connections to key media players, and opportunities for business development through SRMG's vast network. Led by a team with significant media and tech expertise, SRMG Ventures is actively shaping the future of the media landscape, with a focus on emerging trends in immersive tech, generative AI, and content monetization.

St. Paul Venture Capital (SPVC) was a major US early-stage venture capital firm founded in 1988 as the corporate venture capital arm of The St. Paul Companies, later St. Paul Travelers and today Travelers. Headquartered in Eden Prairie, Minnesota with additional offices in Minneapolis, Boston, and Silicon Valley, SPVC was one of the largest early-stage venture firms in the United States, with approximately $3 billion of committed capital across multiple funds. The firm specialized in early-stage investments in technology -- telecommunications, infrastructure, software, and enterprise -- alongside healthcare and medical devices, and made 270 total investments across its active life. The portfolio generated 94 exits across its history. Notable holdings included Santarus in specialty pharmaceuticals, Vendavo in pricing software, and EBR Systems, whose exit in November 2021 represents the firm's most recent disclosed portfolio outcome. Allan Will served as one of the firm's partners. SPVC's scale and breadth made it a formative institution in the Midwest venture ecosystem, with particular depth in healthcare and communications technology. St. Paul Venture Capital is permanently closed. In June 2004 the firm split into two independent successor firms: Split Rock Partners, focused on healthcare and growth-stage information technology, and Vesbridge Partners, focused on communications technology. St. Paul Travelers continued to back both spin-outs with new capital. Since the 2004 split SPVC has made no new primary investments; its continued public profile reflects legacy portfolio holdings and historical disclosures only. The two successor firms operate as distinct and active investment platforms.

Stage Venture Partners, founded in 2015, is a pre-seed and seed stage venture capital firm focusing on emerging software technologies for business-to-business markets. They invest in enterprise software startups that drive significant advancements in their respective fields. The firm is known for being one of the first institutional investors in many of its portfolio companies and for its commitment to supporting founders who are tackling hard problems and creating impactful solutions. Notable investments include companies like Epsilon3, which builds mission management software for the space industry, and GrayMatter Robotics, which automates labor-intensive industrial surface treatment tasks using advanced robotics​. Their portfolio is diverse, encompassing sectors from e-commerce to government technology, and spanning geographies from St. Louis to Seattle​. Stage Venture Partners is led by Alex Rubalcava, the founder and managing partner, who has a long-standing career in venture capital and has been recognized as one of the top VCs in Los Angeles​. The firm is highly regarded for its unique expertise and alignment with the daring visions of its portfolio companies, providing not just capital but also strategic support and industry connections to help these companies scale effectively.

STAR Ventures is one of the first generation of Israeli venture capital firms, founded in 1992 by Dr. Meir Barel and headquartered in Herzliya, Israel, with a long-standing European office in Munich, Germany. Across its multi-decade history, STAR has managed approximately $1 billion of commitments and helped build more than 180 category-leading technology companies, making it one of Israel's most influential early-stage investors. The firm leads rounds and backs companies affiliated with Israel across information technology -- with an emphasis on data, telecommunications, internet, and enterprise software -- alongside semiconductors, enterprise infrastructure, and medical devices and life sciences. Dr. Barel began his career as Investment Manager and later Managing Partner at Techno Venture Management in Germany -- one of the country's largest VC firms -- before establishing STAR with the dual-geography footprint it still maintains. The core team today includes Dr. Barel and Investment Manager Amit Barel. STAR's portfolio has delivered 12 IPOs -- including Rong 360 on NYSE American in November 2017 and BioLineRx on the Tel Aviv Stock Exchange -- and 58 acquisitions, with Deltek as the most recent disclosed exit, acquired by Aktion Associates in September 2025. The firm's most recent disclosed new investment is Parqour in February 2023. Other portfolio names include Insurobo and Progyny Global. STAR's Munich office is not decorative: the firm's German network was built over decades and provides its Israeli portfolio companies with a direct gateway to European enterprise customers and strategic acquirers -- a differentiated channel that younger Israeli funds without pre-existing European infrastructure cannot easily replicate.

Starbridge Venture Capital is an early-stage venture fund focused on space technology and its applications in terrestrial markets. The fund primarily targets "space scalable" companies—those developing technologies that are essential for commercial space activity but also have strong applications on Earth. Starbridge emphasizes companies with proven product-market fit, solid revenue streams, and realistic exit strategies. Their portfolio includes innovative startups such as Axiom Space, which is building a commercial space station, and Umbra Lab, a leader in synthetic aperture radar technology. Starbridge fills a critical gap in funding, particularly for companies that have raised seed capital but struggle to secure Series A and beyond. The fund's approach includes both active engagement with its portfolio companies and a focus on companies that serve commercial and governmental clients. Their investments cover a wide range of industries, from space manufacturing to energy storage and satellite technologies​. The team at Starbridge is composed of experienced professionals in science, technology, and finance, providing the strategic insights necessary to guide companies through periods of high growth and economic uncertainty. This makes them a key player in both the space and terrestrial tech ecosystems.

Starlight Ventures, founded in 2017 and based in Miami, Florida, is a venture capital firm dedicated to addressing the world's most pressing challenges through investment in transformative technologies. With a strong focus on deep tech and tough tech, they invest in industries such as space technology, energy transition, industrial biology, and next-generation platforms​​. The firm’s portfolio includes groundbreaking companies like Satellogic, which specializes in real-time Earth observation through nano-satellites, and Gathered Foods, known for its plant-based fish products​​. Other notable investments include Impossible Metals, working on autonomous underwater vehicles for deep-sea mining, and HelixNano, leveraging synthetic biology and AI for next-generation gene therapies​​. Starlight Ventures typically invests between $250K to $2.5 million in early-stage companies, often leading the rounds and providing strategic guidance and operational support​​. The firm is highly selective, seeking out ventures that offer significant societal and financial returns. The team is led by co-founders Matias Mosse and Patricia Wexler, alongside a diverse group of advisors and venture partners with expertise in various fields. This team-centric approach ensures that they can offer specialized advice and support to their portfolio companies​. Starlight Ventures’ global outlook and strong network enable them to identify and support innovative solutions worldwide, making them a key player in the venture capital landscape​​.

Starquest Capital is a prominent French venture capital firm that specializes in fostering innovation in deep tech and green tech sectors. Their portfolio includes notable investments such as Caeli Energie, which offers groundbreaking green air-conditioning solutions, and DNA Gensee, a company providing DNA-proof ingredient authentication for the food and cosmetic industries. The firm is committed to addressing global challenges, focusing on industries like cleantech, industry 4.0, and cybersecurity. Geographically, Starquest Capital primarily invests in European startups, with a significant emphasis on France. Their investment strategy revolves around identifying disruptive technologies that can generate significant societal and environmental impacts. They typically invest in early to growth-stage companies, with an average check size ranging from €3 to €10 million, often leading the investment rounds. Starquest's team is spearheaded by experienced professionals, including founding partner and CEO Arnaud Delattre, and investment director Chloé Cohen-Aknine, who brings a wealth of experience from her time at Idinvest. Their approach combines strategic vision and hands-on operational support to help entrepreneurs scale their ventures effectively. Startups seeking investment from Starquest are encouraged to approach the firm with a clear demonstration of technological innovation and potential for high impact. The firm values detailed business models that align with their mission to combat climate change and promote sustainability. Starquest Capital is recognized for its active engagement with portfolio companies, providing not just capital but also strategic guidance and resources to drive growth and success.

Starta VC, based in New York, is an early-stage venture capital fund and accelerator focused on supporting international startups. Founded in 2015, Starta VC has a robust portfolio, investing primarily in technology sectors including enterprise applications, high tech, consumer products, AI, and vertical SaaS. Notable investments from Starta VC include Petal, a fintech company offering credit cards to underserved populations; ClassTag, a parent-teacher communication platform; and FriendlyData, a startup that simplifies data access using natural language processing. These companies highlight Starta VC's commitment to backing innovative solutions with significant market potential.

StartUp Health is a venture capital firm dedicated to investing in and supporting health tech startups worldwide. Founded in 2011, it focuses on achieving 12 Health Moonshots, aiming to transform various aspects of health and wellness globally. With over 395 investments in 27 countries across six continents, StartUp Health is a significant player in the digital health ecosystem. Notable companies in their portfolio include Quit Genius, a digital clinic for treating multiple addictions; Gabbi, which developed a breast cancer risk assessment tool; and De Oro Devices, known for its health diagnostics and medical devices​​. StartUp Health typically invests in pre-seed, seed, and Series A stages, offering a $200,000+ benefit package for equity positions of about 2%. Their investment strategy prioritizes companies with innovative solutions and potential for significant impact in the healthcare sector​​. The firm is led by co-founders Steven Krein and Unity Stoakes, who bring extensive experience and a strong commitment to supporting health-focused entrepreneurs. StartUp Health provides its portfolio companies with extensive resources, mentorship, and a global network to help them succeed​.

Startup Wise Guys is a prominent accelerator and early-stage venture capital firm based in Tallinn, Estonia. Since its founding in 2012, it has invested in over 440 startups, focusing on underserved markets primarily in Europe, Africa, and the CIS countries. The firm is renowned for its mentorship-driven accelerator programs, which span various verticals including SaaS, fintech, cybersecurity, sustainability, and web3​. The firm's accelerator programs, which typically last five months, provide early-stage startups with seed capital, office space, and access to a global network of mentors and investors. The programs are designed to help startups scale quickly and achieve substantial monthly recurring revenue. Startup Wise Guys has a strong track record, boasting 15 successful exits, including notable companies like VitalFields, StepShot, and VOCHI. Additionally, their portfolio companies have collectively raised over €461 million in follow-on funding​. The firm's latest initiatives include raising up to €52.5 million across three new funds: the Cyber Fund I, the Challenger Fund II, and the Opportunity Fund II. These funds aim to support startups in cybersecurity, fintech, and other high-potential sectors.